Jubilant Pharmova slips 11% on USFDA observation, weak Q4 results ...Middle East

The United States Food and Drug Administration (US FDA) has classified its inspection of the company's Montreal Canada contract manufacturing (CMO) facility as Official Action Indicated (OAI)

Hence then, the article about jubilant pharmova slips 11 on usfda observation weak q4 results was published today ( Tuesday 30/05/2023 - 08:29 AM ) and is available on Business Standard ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Jubilant Pharmova slips 11% on USFDA observation, weak Q4 results )

Also on site :

• CGTN: polityka wewnętrzna Chin: kluczowe priorytety płynące z inspekcji i spotkań prowadzonych przez prezydenta Xi w 2025 roku
• Gambia: Govt Yet to Confirm Reported Tragic Deaths of 190 Migrants - Trade Minister
• South Korean Company Signs $4 Billion Arms Deal with Poland